Resmed (RMD) Interest Expenses (2009 - 2026)

Resmed's Interest Expenses history runs 18 years deep, the most recent figure standing at $6.5 million for Q1 2026.

• Quarterly Interest Expenses fell 54.05% year-over-year to $6.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $26.9 million (up 118.98% YoY) and the FY2025 annual result came in at $216.3 million, up 373.26% from the prior year.
• Interest Expenses was $6.5 million for Q1 2026 at Resmed, down from $6.6 million in the prior quarter.
• Across five years, Interest Expenses topped out at $15.0 million in Q1 2023 and bottomed at -$19.4 million in Q2 2023.
• A 5-year average of $6.1 million and a median of $6.9 million in 2025 frame the typical range for Interest Expenses.
• Annual changes were most pronounced in 2023 — Interest Expenses slumped 450.7% — and 2025, when it jumped 10121.21%.
• Resmed's Interest Expenses stood at $10.3 million in 2022, then soared by 33.54% to $13.8 million in 2023, then sank by 100.48% to -$66000.0 in 2024, then soared by 10121.21% to $6.6 million in 2025, then decreased by 1.22% to $6.5 million in 2026.
• Business Quant data shows RMD's Interest Expenses at $6.5 million in Q1 2026, $6.6 million in Q4 2025, and $6.9 million in Q3 2025.